Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$28.39 +1.00 (+3.65%)
As of: Nov 11, 2026 · 3:47 PM EST

Arcutis Biotherapeutics (ARQT) Price to Earnings (2026)

Updated

Arcutis Biotherapeutics' (ARQT) Price to Earnings came in at 115.47 for Q2 2026.

Analysis

Arcutis Biotherapeutics (ARQT) Price to Earnings (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Arcutis Biotherapeutics 3.45 Bn 2.51 Bn 131.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 111.36
Jun 30, 2026 115.47
API Access

Arcutis Biotherapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ARQT&period=max&api_key=YOUR_API_KEY